Azenta, Inc.

NASDAQ:AZTA

Medical - Instruments & Supplies

Healthcare
$48.69 -0.11%

-$0.03 today

Market cap
$2.13B
Beta
1.40
P/E (TTM)
-5.9
EPS (TTM)
-$3.87
52W Low $15.93High $41.73

Volume 0.69M

Average 1.16M

AZTA Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Azenta, Inc.NASDAQ: AZTA

Common Stock · Q4 FY2026 · quarter ended Sep 2026

Common stock falls 6.9% from a year ago

Common stock stood at $553K at the end of Q4 FY2026, down 6.9% from a year earlier and down 3.3% from the prior quarter. Over 3 fiscal years it compounded at -8.1% a year.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q4 FY2026, unchanged from a year earlier.
  • Common stock increased in 1 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps falling in the next quarterly balance sheet after a -6.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$553K-3.3% QoQ
Last fiscal yearSep 2026
$553K-6.9% YoY
Year agoSep 2025
$594K-6.9% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.9%——
1 year-6.9%——
3-year CAGR-8.1%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2026
553K USD
Year-over-year change
-6.9%
4-year CAGR
-11.1%

Common Stock vs competitors

How AZTA compares with its peers on the latest reported figures

  • AZTA's Sep 2026 common stock of $553K is the 7th highest of the 10 companies compared; the peer median is $1.8M.
  • Its year-over-year change of -6.9% is the 8th highest of 9, against a peer median of +0.2%.
  • Common stock amounts to 0.0% of total assets for AZTA, versus a peer median of 0.0%.
AZTA Competitors Peer median
Common Stock for AZTA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MLABMesa Laboratories, Inc.Mar 2026$375.35M +4.7%+4.2%87.8%
NEOGNeogen CorporationAug 2026$34.9M +0.4%+0.2%1.1%
DHRDanaher CorporationSep 2026$9M +0.0%+0.0%0.0%
SOLVSolventum CorporationJun 2026$2M +0.0%—0.0%
BRKRBruker CorporationJun 2026$1.8M +0.0%+1.9%0.0%
TECHBio-Techne CorporationSep 2026$1.57M +0.9%-0.3%0.1%
AZTAAzenta, Inc.Sep 2026$553K -6.9%-8.1%0.0%
BLFSBioLife Solutions, Inc.Mar 2026$49K +2.1%+3.7%0.0%
TMOThermo Fisher Scientific Inc.Sep 2026$0 -100.0%+0.3%0.0%
BIOBio-Rad Laboratories, Inc.Jun 2026$0 ——0.0%
Peer median (excluding AZTA) $1.8M+0.2%+0.3%0.0%

Competitors are the stored peer set for AZTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Cash & Equivalents658.27M678.91M310.93M279.78M193.8M
Short-term Investments911.76M338.87M151.16M61.14M138.89M
Net Receivables163.76M156.54M172.71M189.21M154.14M
Inventory85.54M128.2M115.26M74.96M77.12M
Other Current Assets507.39M116.44M82.75M103.25M59.6M
Total Current Assets2.46B1.42B832.81M708.34M623.54M
Property, Plant & Equipment (Net)154.47M205.74M266.65M208M234.26M
Goodwill513.62M784.34M691.41M702.4M546.26M
Intangible Assets178.4M294.3M248.03M101.81M80M
Long-term Investments352.02M111.34M49.45M247.19M169.2M
Tax Assets1.17M571K837K726K499K
Other Non-current Assets57.09M70.47M10.86M91.12M54.63M
Total Non-current Assets1.26B1.47B1.27B1.35B1.08B
Total Assets3.72B2.89B2.1B2.06B1.71B
Account Payables38.65M35.8M44.43M37.72M55.22M
Short-term Debt0007.78M0
Tax Payables28.42M7.38M13.28M9.73M10.72M
Deferred Revenue39.75M34.61M31.98M32.57M40.08M
Other Current Liabilities81.83M99.23M104.5M114.39M59.21M
Total Current Liabilities230.55M210.93M204.84M237.67M233.09M
Long-term Debt00051.24M0
Deferred Tax Liabilities66.24M67.68M54.18M18.25M15.34M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities6.72M12.18M11.93M(28.61M)10.86M
Total Non-current Liabilities122.19M140.29M126.24M93.02M78.08M
Total Liabilities352.74M351.22M331.07M330.7M311.16M
Common Stock885K713K590K594K553K
Retained Earnings1.66B1.64B1.48B1.42B1.25B
Accumulated OCI(83.92M)(62.43M)(13.46M)(22.21M)(77.4M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.36B2.53B1.77B1.73B1.4B
Total Debt49.23M60.44M70.68M111.17M51.87M
Net Debt(609.05M)(618.47M)(240.25M)(168.61M)(141.92M)

Azenta, Inc.

NASDAQ:AZTA

Intrinsic Alpha fair value

Locked

Current Price

$48.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.